NCT01939314View on ClinicalTrials.gov

Sphenopalatine Nerve Block for Headache Tx360

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HeadacheMigraine
Interventions
DRUG

Bupivacaine

Bupivavaine Delivered by the Tx 360 Device to the Sphenopalatine Ganglion

DRUG

Placebo

Normal Saline Delivered by the Tx 360 Device to the Sphenopalatine Ganglion

Trial Locations (1)

46202

Indiana University, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT01939314 - Sphenopalatine Nerve Block for Headache Tx360 | Biotech Hunter | Biotech Hunter